CreativeOne Wealth’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-741
Closed -$201K 792
2024
Q1
$201K Buy
+741
New +$177K 0.01% 840
2023
Q3
Sell
-1,166
Closed -$245K 630
2023
Q2
$245K Sell
1,166
-9
-0.8% -$1.79K 0.01% 709
2023
Q1
$237K Buy
1,175
+18
+2% +$4.08K 0.01% 706
2022
Q4
$252K Sell
1,157
-32
-3% -$6.99K 0.01% 633
2022
Q3
$234K Buy
1,189
+30
+3% +$6.48K 0.01% 630
2022
Q2
$248K Sell
1,159
-301
-21% -$73.5K 0.01% 613
2022
Q1
$414K Sell
1,460
-1,019
-41% -$314K 0.02% 484
2021
Q4
$934K Buy
2,479
+372
+18% +$145K 0.05% 300
2021
Q3
$870K Buy
2,107
+183
+10% +$76K 0.05% 283
2021
Q2
$712K Buy
+1,924
New +$642K 0.04% 312
2021
Q1
Sell
-1,331
Closed -$332K 569
2020
Q4
$332K Buy
+1,331
New +$317K 0.03% 354

Other funds holding CRL

CreativeOne Wealth's CRL Position: Q2 2024 in Review

CreativeOne Wealth sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 741 shares — an estimated $201K sold.

CreativeOne Wealth first reported a position in CRL in Q4 2020 and held it in 11 quarters. The position peaked at $934K in Q4 2021. 664 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • CreativeOne Wealth reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • CreativeOne Wealth sold 741 Charles River Laboratories shares in Q2 2024, an estimated $201K.
  • CreativeOne Wealth first reported a position in Charles River Laboratories in Q4 2020 and held it in 11 quarters.
  • CreativeOne Wealth's Charles River Laboratories position peaked at $934K in Q4 2021.
  • 664 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on CreativeOne Wealth's 13F filing for Q2 2024, filed 14 Aug 2024.